Propanc Biopharma, Inc. (PPCB) Starts Presentation at LD Micro Main Event
Propanc Biopharma (OTC: PPCB) is a clinical stage biopharmaceutical company developing new cancer treatments initially for patients suffering from pancreatic, ovarian and colorectal cancers. Propanc has developed a formulation of anti-cancer compounds, which exert a number of effects designed to control or prevent tumors from recurring and spreading throughout the body. Propanc’s products involve or employ pancreatic proenzymes, which are inactive precursors of enzymes. In the near term, the company intends to target patients with limited remaining therapeutic options for the treatment of solid tumors. In future, it intends to develop products to treat early stage cancer, pre-cancerous diseases and…







